Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RAD54L2 pseudogene 1 (RAD54L2P1) is a genomic DNA sequence hypothesized to be derived from the functional RAD54-like 2 (RAD54L2) gene. There is currently no evidence in scientific literature or major databases for the existence of a functional gene or protein product named 'RAD54L2 pseudogene 1'. By definition, a pseudogene like RAD54L2P1 would be non-functional, not encode a protein, and therefore lacks biological or therapeutic significance. All established biological functions, molecular mechanisms, disease roles, and therapeutic implications are associated with the active RAD54L2 gene, which is an SNF2-family ATPase involved in DNA repair and genome stability, and is considered a therapeutic target in contexts such as cancer resistance to TOP2 inhibitors. The term 'RAD54L2P1' is likely incorrect or refers to a non-functional genomic element.
RAD54L2 pseudogene 1 (RAD54L2P1) is a pseudogene and, as such, does not encode a functional protein and has no known molecular mechanism of action. All known mechanisms, such as the dissociation of TOP2-DNA complexes via ATPase activity, are attributed to the functional RAD54-like 2 (RAD54L2) gene, not its pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RAD54L2 pseudogene 1 (RAD54L2P1).